Pharmaceutical Business Review
Anonymous User | Login

Takeda Files NDA For Fixed-Dose Combination Tablet Of Actos With Sulfonylurea In Japan

Published: 27-Jul-2009

Combination tablet, for the treatment of type 2 diabetes

Takeda has filed a New Drug Application (NDA) to the Japanese Ministry of Health, Labour and Welfare, for a fixed-dose combination tablet of Actos with sulfonylurea. The drug is intended for the treatment of type 2 diabetes.

A fixed-dose combination tablet of Actos with sulfonylurea was approved under the brand name - Duetact in the US in July 2006. It was approved under the brand name of Tandemact in the EU in January 2007.

Nancy Joseph-Ridge, general manager, Pharmaceutical Development Division of Takeda, said: “Since there are also many cases where Actos and sulfonylurea are administered in combination in Japan, we are expecting that a fixed-dose combination tablet of Actos with sulfonylurea, if approved, will positively contribute to the treatment of Japanese patients with diabetes as well.”

Share

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Almac

Drug Development Solutions ...

GRACO

World Leader in Fluid Handling Systems and Components ...

Burkert Fluid Control Systems

Fluid and Gas Control Systems ...

eResearch Technology

Provider of Technology and Services ...

Umicore Precious Metals Chemistry

Chemicals and Catalysts for Industrial Applications ...

PFC Pharma Focus

Planning And Conducting Clinical Phase I To IV Studies ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

GRACO's New FDA Pumps

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

GRACO's New Hydra-Clean

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

GRACO's New 1590 & 3150 Pumps

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

Customer Testimonial – Astra Zeneca

From the control room to the downstream processing area and with an eye on utilities servi ...

Hygienic Processing

From the control room to the downstream processing area and with an eye on utilities servi ...

Related Companies

Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co., Ltd. (Santen) is a pharmaceutical company based in Japan. Th ...

Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (Takeda) is a global pharmaceutical company mainl ...

Eisai Co., Ltd.

Eisai Co., Ltd. (Eisai) is a Japanese pharmaceutical company focused on researching, de ...

Chugai Pharmaceutical Co. Ltd

Chugai Pharmaceutical Co., Ltd. (Chugai Pharmaceutical) is a pharmaceutical company eng ...

Mochida Pharmaceutical Co., Ltd.

Mochida Pharmaceutical Co., Ltd (Mochida) is a Japan based healthcare company. The com ...

Suppliers Product News

Almac Completes Phase One of Its Expansion Plan to Pharma Services Facilities

New $15m facility will "meet growing business need for its integrated product development and commercial services."

ERT Launches New Online Gateway to Improve Cardiac Safety in Clinical Trials

ERT, a leading provider of centralized ECG, ePRO, eClinical technology and other services to the biopharmaceutical, medical device and related industries, announced today the launch of a unique online web interface – My Study Portal.

ERT Officials Ring the NASDAQ Closing Bell

ERT (NASDAQ: ERES), a leading provider of centralized ECG and eClinical technology, ePRO and other services to the biopharmaceutical, medical device and related industries, closed the stock market on 18 June by ringing the famous NASDAQ bell.

ERT Relocates Customer Care Team to Provide Stronger Client Support

ERT a leading provider of centralized ECG, ePRO, eClinical technology and other services to the biopharmaceutical, medical device and related industries, is to move its dedicated customer care team to its new state-of-the-art headquarters and logistics operations in Philadelphia.

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address